248 related articles for article (PubMed ID: 15264123)
1. Paraneoplastic cholestasis associated with prostate carcinoma.
Koruk M; Büyükberber M; Savaş C; Kadayifçi A
Turk J Gastroenterol; 2004 Mar; 15(1):53-5. PubMed ID: 15264123
[TBL] [Abstract][Full Text] [Related]
2. Cholestatic jaundice as a paraneoplastic manifestation of prostate adenocarcinoma.
Karakolios A; Kasapis C; Kallinikidis T; Kalpidis P; Grigoriadis N
Clin Gastroenterol Hepatol; 2003 Nov; 1(6):480-3. PubMed ID: 15017648
[TBL] [Abstract][Full Text] [Related]
3. [Cholestasis and prostatic carcinoma. Description of a case and review of paraneoplastic cholestasis].
Morís de la Tassa J; Claros González I; García-Alcalde Fernández ML; Antuña Egocheaga A; Argüelles Toraño M
Med Clin (Barc); 1991 Jan; 96(1):22-5. PubMed ID: 2023465
[TBL] [Abstract][Full Text] [Related]
4. Cholestatic Jaundice as a Paraneoplastic Manifestation of Prostate Cancer Aggravated by Steroid Therapy.
Kang MK; Park JG; Lee HJ
Med Princ Pract; 2018; 27(2):197-200. PubMed ID: 29320775
[TBL] [Abstract][Full Text] [Related]
5. Stauffer's syndrome variant associated with renal cell carcinoma.
Giannakos G; Papanicolaou X; Trafalis D; Michaelidis I; Margaritis G; Christofilakis C
Int J Urol; 2005 Aug; 12(8):757-9. PubMed ID: 16174051
[TBL] [Abstract][Full Text] [Related]
6. Metastatic prostate cancer presenting as paraneoplastic pemphigus: a favourable clinical response to combined androgen blockade and conventional immunosuppressive therapy.
Mignogna MD; Fortuna G; Leuci S; Adamo D; Ruoppo E
Br J Dermatol; 2009 Feb; 160(2):468-70. PubMed ID: 19120335
[No Abstract] [Full Text] [Related]
7. [Neuroendocrine differentiation in adenocarcinoma of the prostate during hormonal treatment: a case report].
Matsumoto Y; Mibu H; Kagebayashi Y
Hinyokika Kiyo; 2004 Nov; 50(11):813-5. PubMed ID: 15628545
[TBL] [Abstract][Full Text] [Related]
8. [Neuroendocrine differentiation in adenocarcinoma of prostate during combined androgen blockade therapy: a case report].
Kitamoto K; Hayashi T; Tamada S; Ezaki K; Kawashima H; Sugimura K; Nakatani T
Hinyokika Kiyo; 2005 Jan; 51(1):33-5. PubMed ID: 15732339
[TBL] [Abstract][Full Text] [Related]
9. Management of the mucin filled bile duct. A complication of intraductal papillary mucinous tumor of the pancreas.
Patel A; Lambiase L; Decarli A; Fazel A
JOP; 2005 May; 6(3):255-9. PubMed ID: 15883476
[TBL] [Abstract][Full Text] [Related]
10. Severe jaundice, due to vanishing bile duct syndrome, as presenting symptom of Hodgkin's lymphoma, fully reversible after chemotherapy.
Leeuwenburgh I; Lugtenburg EP; van Buuren HR; Zondervan PE; de Man RA
Eur J Gastroenterol Hepatol; 2008 Feb; 20(2):145-7. PubMed ID: 18188038
[TBL] [Abstract][Full Text] [Related]
11. Stauffer's syndrome with jaundice, a paraneoplastic manifestation of renal cell carcinoma: a case report.
Tomadoni A; García C; Márquez M; Ayala JC; Prado F
Arch Esp Urol; 2010 Mar; 63(2):154-6. PubMed ID: 20378939
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of fosinopril-induced severe cholestatic jaundice with plasma exchange.
Chou JW; Yu CJ; Chuang PH; Lai HC; Hsu CH; Cheng KS; Peng CY; Chiang IP
Ann Pharmacother; 2008 Dec; 42(12):1887-92. PubMed ID: 19017832
[TBL] [Abstract][Full Text] [Related]
13. [Obstructive jaundice in prostate neoplasm. Case report].
Whittle C; Salgado G; Schiappacasse G; Vela H
Rev Med Chil; 1999 Dec; 127(12):1493-6. PubMed ID: 10835758
[TBL] [Abstract][Full Text] [Related]
14. [Combined small-cell carcinoma/adenocarcinoma of prostate: report of two cases].
Sakuma T; Yoshida T; Ohashi H; Nishimura K; Kawano K
Hinyokika Kiyo; 2007 Jul; 53(7):489-92. PubMed ID: 17702184
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic cholestatic jaundice may be a paraneoplastic manifestation of underlying malignancy: a case of prostate cancer.
Okano A; Ohana M; Kusumi F
Clin J Gastroenterol; 2014 Jun; 7(3):278-82. PubMed ID: 26183750
[TBL] [Abstract][Full Text] [Related]
16. Fulminant digital necrosis in a patient with prostate adenocarcinoma.
Paolini MV; Jankilevich G; Graziano C; Fernández Romero DS
Allergol Immunopathol (Madr); 2010; 38(1):48-50. PubMed ID: 19836875
[No Abstract] [Full Text] [Related]
17. Prostatic carcinoma metastatic to the paranasal sinuses: a case report.
Viswanatha B
Ear Nose Throat J; 2008 Sep; 87(9):519-20. PubMed ID: 18800324
[TBL] [Abstract][Full Text] [Related]
18. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
Okegawa T; Nutahara K; Higashihara E
J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
[TBL] [Abstract][Full Text] [Related]
19. [Cutaneous lymphangitic carcinomatosis and acquired ichtyosis associated with prostatic carcinoma].
Drappier JC; Mahé E; Memin A; Grossin M; Descamps V; Belaïch S; Legrain S; Crickx B
Ann Dermatol Venereol; 2003 Mar; 130(3):345-7. PubMed ID: 12746672
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer tissue is masked by bicalutamide: a case report.
Ellinger J; Bastian PJ; Biermann K; Schmidt ME; Textor J; Bollmann D; Zhou H; Müller SC
Eur J Med Res; 2007 May; 12(5):212-5. PubMed ID: 17513193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
